Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CT Scan-Based Radiomics and Molecular Expression Predictive Model to Assess Tumor Regression Grade Following Perioperative Chemotherapy in Esophago-Gastric Junction and Gastric Cancer

NCT04878783 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT04878783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04878783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CT Scan-Based Radiomics and Molecular Expression Predictive Model to Assess Tumor Regression Grade Following Perioperative Chemotherapy in Esophago-Gastric Junction and Gastric Cancer
Lead sponsor
University of Roma La Sapienza
Phase
Observational
Overall status
Active, not recruiting
Start date
December 20, 2019
Completion date
October 30, 2027
Enrollment
138 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the stomach, gastric cancer